StockWatch
·
Q1 FY-2027 RESULTS · CANHLIFE

Canara HSBC Life Q1: PAT ₹28 Cr, up 20% YoY on 24% premium growth; QoQ dip is seasonal

PAT +20.2% YoY · revenue +23.8% · margins compressing

Q1 FY27 resultsCANHLIFECanara HSBC Life Insurance Company Ltd20 Jul 2026 · 3 min read
Revenue

₹2,047.52 Cr

+23.8% YoY

PAT (standalone)

₹28.14 Cr

+20.2% YoY

Net margin

0.65%

EPS

₹0.3

Canara HSBC Life Insurance's first result of FY27 (standalone; it has no subsidiaries, so no consolidated statement exists) shows shareholders' profit after tax of ₹28.14 Cr, up 20.2% from ₹23.42 Cr in the year-ago June-2025 quarter, with basic EPS of ₹0.30 (₹0.25 a year ago). Net premium income rose 23.8% YoY to ₹2,047.52 Cr from ₹1,653.43 Cr, so the topline grew a shade faster than the bottom line — a mild profit-level squeeze visible in the Expenses-of-Management ratio, which ticked up to 20.7% from 19.6% a year earlier. The sequential comparison (PAT ₹34.73 Cr and net premium ₹5,060.66 Cr in Q4 FY26) looks like a sharp fall, but life insurance is heavily Q4-weighted and the company itself flags (Note 6) that interim results are not indicative — the QoQ drop is a seasonality artifact, not a slowdown; YoY is the read that matters, and it is solid double-digit growth on both lines.

The scoreboard

Q1 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹2,047.52 Cr+5038.5%
Expenses₹4,279.18 Cr+5444.3%
PAT₹28.14 Cr-19%+20.2%
Net margin0.65%+84.4pp
EPS₹0.3-18.9%

No year-ago quarter on record — YoY cells may be blank.

The eye-catching ₹2,268.79 Cr of investment income (total income ₹4,346.98 Cr) is not a profit driver: per Note 2 it is mark-to-market gains on equities inside Unit-Linked funds, a policyholder pass-through that is almost entirely offset by the ₹2,997.31 Cr increase in actuarial liability on the expense side, leaving shareholder PBT at ₹31.51 Cr. Shareholders' own investment income was the smaller, real contributor, at ₹34.55 Cr vs ₹25.88 Cr YoY. Solvency stands at a comfortable 198% (190% at Mar-26, 200% Jun-25), and the ₹250 Cr of subordinate debt (₹25,000 Lakh borrowings) now sits on the balance sheet — directly executing the capital-raise management laid out on the Q3 FY26 concall.

132.58138.39144.19149.99155.815004-1605-0906-0206-2407-1707-20Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹150, up 5.8% over the past month of trading.

₹ Cr
015.2430.4745.7140.81Q2 FY26rev ₹71 Cr27.65Q3 FY26rev ₹129 Cr34.73Q4 FY26rev ₹-41 Cr
Quarterly standalone PAT, ₹ Crore
What management guided (3 FY-2026 call)
Management guides for continued strong growth, outpacing the industry, with a strategic focus on improving the product mix in Q4 to bring the full-year ULIP share to ~55%. The company anticipates a full-year VNB margin impact of approximately 185 basis points from GST changes, which it is actively mitigating through a

This quarter: met

The quarter delivers against the prior guidance of growth continuing to outpace the industry (WPI was up 19% and gross premium crossed ₹10,000 Cr in FY26, and premium momentum carried into Q1) and the planned sub-debt raise, both of which are visible in the print. It also lands alongside distribution and governance actions this quarter — a new corporate-agency tie-up with West Bengal Gramin Bank, board re-appointment of two directors, and the appointment of joint statutory auditors Brahmayya & Co. and Raj Har Gopal & Co., who have issued a clean limited-review report. There is no published street consensus for this recently-listed insurer's Q1, so the print cannot be benchmarked to estimates; management's own concall targets — lifting full-year ULIP mix toward ~55%, growing protection to a double-digit share, and mitigating an ~185 bps VNB-margin hit from GST changes — are the yardsticks to check next quarter.

What to watch

  • W1

    Product mix: management targeted full-year ULIP share ~55% and a double-digit protection share — verify the shift as FY27 progresses (Q1 net premium ₹2,047.52 Cr base).

  • W2

    Cost trajectory: Expenses-of-Management ratio 20.7% (vs 19.6% YoY) — watch whether the cost-efficiency drive management flagged pulls it back.

  • W3

    VNB-margin: guided ~185 bps full-year hit from GST changes being mitigated — check margin disclosure through the year; solvency to hold above the 198% level after the ₹250 Cr sub-debt.

Life-insurer format (Policyholders' + Shareholders' A/c), source in Lakhs. revenueFromOps=Net Premium Income; totalIncome=Policyholders Total(2-5); totalExpenses=Total(10-16). PBT/PAT/EPS taken from Shareholders' A/c (standard insurer P&L) and confirmed on the Reg-52(4) disclosure page. PBT is NOT totalIncome-totalExpenses in insurer format (net of policyholder-surplus transfer) — do not force that check; PAT=PBT-tax (3,151-337=2,814) reconciles. Total(2-5) reconciles only if the row-5 shareholder-transfer OCR'd as 7,408 is read as 2,408 (=row-24). No consolidated: Note 1 — no subsidiaries. Big investment income (₹2,268.79 Cr) is MTM equity gain in ULIP funds, a policyholder pass-through offset by the ₹2,997.31 Cr rise in actuarial liability.

Informational and educational content only. Not investment advice.